Bausch, Lannett settlements with US states get final nod in generic drug antitrust case
MLex Summary: Bausch Health and Lannett Company’s settlements with US states have been granted final approval to resolve allegations that they conspired to artificially inflate and manipulate prices for numerous generic...To view the full article, register now.
Already a subscriber? Click here to view full article